|
Volumn 8, Issue 3, 2000, Pages 160-163
|
The immunogenicity and reactogenicity of the trivalent vaccine, Trimovax(tm), indicated for prevention of measles, mumps, and rubella, in 12-month-old children in Belarus
a a a a a a a a |
Author keywords
Immunogenicity; Measles; MMR; Mumps; Rubella
|
Indexed keywords
ANTIBODY;
MEASLES MUMPS RUBELLA VACCINE;
ANTIBODY BLOOD LEVEL;
ANTIBODY TITER;
ARTICLE;
BELARUS;
CHILD;
CLINICAL TRIAL;
CONJUNCTIVITIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COUGHING;
DRUG INDUCED DISEASE;
DRUG SAFETY;
EXCITABILITY;
HUMAN;
IMMUNITY;
IMMUNOGENICITY;
INFANT;
MAJOR CLINICAL STUDY;
MEASLES;
MUMPS;
RANDOMIZED CONTROLLED TRIAL;
RASH;
RUBELLA;
SORE THROAT;
VACCINATION;
ANTIBODIES, VIRAL;
BYELARUS;
HUMANS;
INFANT;
MEASLES;
MEASLES-MUMPS-RUBELLA VACCINE;
MUMPS;
RUBELLA;
|
EID: 0033805399
PISSN: 12107778
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (24)
|